Patients' Right to Know Their Medication Act of 2023
This bill establishes requirements relating to the form, content, and distribution of patient safety labels for prescription drugs.
Specifically, the Food and Drug Administration must issue regulations with requirements relating to the authorship, content, format, color, printing, and dissemination of such patient safety information. The regulations must require labels to include the drug's approved uses, known interactions with other drugs or substances, contact information for the drug's manufacturer, and other specified information relating to patient safety. The information must be in plain, neutral language and must be given in printed form with each prescription.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.